

| Salt Composition: | Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg) |
| Manufacturer: | Forschung India |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Glykit-MV 2 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels. Glykit-MV 2 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Glykit-MV 2 Tablet SR is a combination of three antidiabetic medicines:
What is Glykit-MV 2 Tablet SR?
Glykit-MV 2 Tablet SR contains Glimepiride, Metformin, and Voglibose, all of which are used in treating Type 2 Diabetes mellitus (DM). This combination helps to improve blood glucose levels. The medicines work differently: Glimepiride helps the pancreas release more insulin; Metformin reduces glucose production by the liver, and improves insulin sensitivity, and Voglibose targets alpha-glucosidase, which lowers postprandial (after meal) glucose levels. This treatment is not recommended for Type 1 Diabetes.
What are possible side effects of Glykit-MV 2 Tablet SR?
Common side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection. These can occur in some patients using this medicine.
Are there any specific conditions where Glykit-MV 2 Tablet SR should not be taken?
Patients with allergies to any components of the medication or excipients must avoid use. Patients with moderate to severe kidney disease, inflammatory bowel diseases (IBD), colonic ulcers and underlying metabolic acidosis including diabetic ketoacidosis should also avoid Glykit-MV 2 Tablet SR.
Is it safe to take alcohol while I am taking Glykit-MV 2 Tablet SR?
No, alcohol may interact with Glykit-MV 2 Tablet SR. It can worsen low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Can Glykit-MV 2 Tablet SR cause hypoglycemia?
Yes, Glykit-MV 2 Tablet SR can contribute to hypoglycemia. Common symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. It is more likely to occur if you skip meals or drinks alcohol, exercise excessively, or combine the medication with other antidiabetic drugs.
What are the storage and disposal instructions for Glykit-MV 2 Tablet SR?
Keep this medicine in its original packaging, tightly closed, and store according to the instructions on the label. Do not allow pets, children, or others to access this medication. Dispose of any unused portions safely.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glykit-MV 2 Tablet SR is to be taken empty stomach.
Alcohol
It is unsafe to consume alcohol with Glykit-MV 2 Tablet SR.
Breastfeed
Glykit-MV 2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Glykit-MV 2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.